RYR2 and heart failure: Altogether our results show that hiPSC-CMs that are heterozygous for RYR2 expression show calcium handling dysfunction, altered glucose metabolism, differential pharmacological responses and increased sensitivity to redox alterations, and serve as a genetically engineered model for mimicking some aspects of heart failure phenotypes.